documents: FDA-2026-N-3273-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-3273-0001 FDA FDA-2026-N-3273 Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments Notice Request for Comments 2026-04-15T04:00:00Z 2026 4 2026-04-15T04:00:00Z 2026-07-24T03:59:59Z 2026-04-15T17:05:22Z 2026-07248 1 0 09000064b9282224

Links from other tables